Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 18760-80-0
2. Rac-methyl Ephedrine Hydrochloride
3. L-n-methylephedrine Hydrochloride
4. Methy-f (tn)
5. Chebi:79398
6. Dtxsid40916196
7. (+/-)-n-methylephedrine Hydrochloride
8. Dl-methylephedrine Hydrochloride (jp17)
9. D02109
10. 760m800
11. J-012074
12. Q27148434
13. 2-(dimethylamino)-1-phenylpropan-1-ol--hydrogen Chloride (1/1)
| Molecular Weight | 215.72 g/mol |
|---|---|
| Molecular Formula | C11H18ClNO |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 215.1076919 g/mol |
| Monoisotopic Mass | 215.1076919 g/mol |
| Topological Polar Surface Area | 23.5 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 141 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A C13639 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of C13639, including repackagers and relabelers. The FDA regulates C13639 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. C13639 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A C13639 supplier is an individual or a company that provides C13639 active pharmaceutical ingredient (API) or C13639 finished formulations upon request. The C13639 suppliers may include C13639 API manufacturers, exporters, distributors and traders.
C13639 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of C13639 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right C13639 GMP manufacturer or C13639 GMP API supplier for your needs.
A C13639 CoA (Certificate of Analysis) is a formal document that attests to C13639's compliance with C13639 specifications and serves as a tool for batch-level quality control.
C13639 CoA mostly includes findings from lab analyses of a specific batch. For each C13639 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
C13639 may be tested according to a variety of international standards, such as European Pharmacopoeia (C13639 EP), C13639 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (C13639 USP).
LOOKING FOR A SUPPLIER?
